ATRION (Nasdaq: ATRI) is expected to report Q1 earnings around Feb. 28. Here's what Wall Street wants to see:

The 10-second takeaway
 Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict ATRION's revenues will expand 7.5% and EPS will grow 27.2%.

The average estimate for revenue is $31.4 million. On the bottom line, the average EPS estimate is $3.37.

Revenue details
 Last quarter, ATRION booked revenue of $28.5 million. GAAP reported sales were 12% higher than the prior-year quarter's $25.5 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
 Last quarter, EPS came in at $2.42. GAAP EPS of $2.42 for Q4 were 8.7% lower than the prior-year quarter's $2.65 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Recent performance
 For the preceding quarter, gross margin was 44.7%, 510 basis points worse than the prior-year quarter. Operating margin was 24.7%, 520 basis points worse than the prior-year quarter. Net margin was 17.2%, 390 basis points worse than the prior-year quarter.

Looking ahead

The full year's average estimate for revenue is $125.2 million. The average EPS estimate is $13.46.

Investor sentiment
 The stock has a four-star rating (out of five) at Motley Fool CAPS, with 255 members out of 264 rating the stock outperform, and nine members rating it underperform. Among 81 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 80 give ATRION a green thumbs-up, and one give it a red thumbs-down.

Is ATRION the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.